MedTrace Logo

Child and Adolescent Anxiety Disorders (CAMS)

NCT00052078 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 488

Last updated 2017-09-19

Study results available
· View outcomes & findings →

Summary

This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.

Conditions

  • Anxiety Disorders
  • Social Phobia
  • Generalized Anxiety Disorder

Interventions

DRUG

Sertraline (SRT)

Participants were treated with sertraline.

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

Participants received CBT.

DRUG

Placebo

Participants were treated with a placebo pill.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2007-10-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00052078 on ClinicalTrials.gov